CEO and President
Thu, Dec 15, 2022
Dec 15
22,794 shares @ $19.86
Decreased holdings by -57.00%
4th largest trade (out of 107)
Trade made by an officer
Unscheduled trade
Insider trade was 94% below market price
Price 41% above 200-day moving average
BTAIBioXcel Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+5.34%
1M+12.20%
3M—
6M—
1Y—